Literature DB >> 19262705

We have entered a new era of adjuvant/neoadjuvant therapy for gastric cancer.

Takeshi Sano1.   

Abstract

Entities:  

Year:  2007        PMID： 19262705      PMCID： PMC2632525     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN： 1934-7820


× No keyword cloud information.
  3 in total

1.  Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.

Authors:  J S Macdonald; S R Smalley; J Benedetti; S A Hundahl; N C Estes; G N Stemmermann; D G Haller; J A Ajani; L L Gunderson; J M Jessup; J A Martenson
Journal:  N Engl J Med       Date:  2001-09-06       Impact factor: 91.245

2.  Adjuvant and preoperative therapy for localized gastric cancer.

Authors:  Yixing Jiang; Alberto J Montero; Kevin F Staveley-O'Carroll
Journal:  Gastrointest Cancer Res       Date:  2007-07

3.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.

Authors:  David Cunningham; William H Allum; Sally P Stenning; Jeremy N Thompson; Cornelis J H Van de Velde; Marianne Nicolson; J Howard Scarffe; Fiona J Lofts; Stephen J Falk; Timothy J Iveson; David B Smith; Ruth E Langley; Monica Verma; Simon Weeden; Yu Jo Chua
Journal:  N Engl J Med       Date:  2006-07-06       Impact factor: 91.245
  3 in total
  2 in total

1.  Significance of lavage cytology in advanced gastric cancer patients.

Authors:  Takeo Fukagawa; Hitoshi Katai; Makoto Saka; Shinji Morita; Yuko Sasajima; Hirokazu Taniguchi; Takeshi Sano; Mitsuru Sasako
Journal:  World J Surg       Date:  2010-03       Impact factor: 3.352

2.  A systematic review and meta-analysis of gastric cancer treatment in patients with positive peritoneal cytology.

Authors:  Carlos Suhady Cabalag; Steven Tuck Foo Chan; Yui Kaneko; Cuong Phu Duong
Journal:  Gastric Cancer       Date:  2014-06-03       Impact factor: 7.370
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.